DNASE1 and inflammation: This airway inflammation model combines both neutrophilic and eosinophilic characteristics to simulate severe respiratory inflammatory disorders, for which Dex therapy is not fully effective.[57] Consistent with previous studies using DNase I,[58] our work showed that B‐PM could reduce cfDNA level and NETs production, and effectively relieve airway inflammation and mucus secretion.